Clinical Trials Directory

Trials / Completed

CompletedNCT00862914

Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Ruhr University of Bochum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

MicroRNAs (miRNAs) are very small endogenous RNA molecules about 22-25 nucleotides in length, capable of post-transcriptional gene regulation. miRNAs bind to their target messenger RNAs (mRNAs), leading to cleavage or suppression of target mRNA translation based on the degree of complementarity. miRNAs have recently been shown to play pivotal roles in diverse developmental and cellular processes and linked to a variety of skin diseases and cancers. In the present study the researchers investigate the immunohistochemical distribution of Dicer in benign and dysplastic melanocytic naevi as well as in cutaneous malignant melanoma compared to intraindividual healthy control.

Conditions

Timeline

Start date
2008-07-01
Primary completion
2009-02-01
Completion
2009-03-01
First posted
2009-03-17
Last updated
2012-10-16

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00862914. Inclusion in this directory is not an endorsement.